(Q47739965)

English

The compound (3-{5-[(2,5-dimethoxyphenyl)amino]-1,3,4-thiadiazolidin-2-yl}-5,8-methoxy-2H-chromen-2-one) inhibits the prion protein conversion from PrPC to PrPSc with lower IC50 in ScN2a cells

scientific article published on 19 September 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/28951092

The compound (3-{5-[(2,5-dimethoxyphenyl)amino]-1,3,4-thiadiazolidin-2-yl}-5,8-methoxy-2H-chromen-2-one) inhibits the prion protein conversion from PrPC to PrPSc with lower IC50 in ScN2a cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/28951092

prion protein family

0 references

4

object named as

David S Wishart

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/28951092

author name string

Nataraj S Pagadala

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/28951092

Trent C Bjorndahl

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/28951092

Michael Joyce

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/28951092

Khajamohiddin Syed

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/28951092

Abdolamir Landi

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/28951092

language of work or name

0 references

publication date

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/28951092

Bioorganic & Medicinal Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/28951092

25

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/28951092

20

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/28951092

5875-5888

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/28951092

A structural overview of the vertebrate prion proteins

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Cultured cell sublines highly susceptible to prion infection

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

A Computer Program for Classifying Plants

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Potent inhibition of scrapie prion replication in cultured cells by bis-acridines

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Prion protein NMR structure from tammar wallaby (Macropus eugenii) shows that the beta2-alpha2 loop is modulated by long-range sequence effects

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

In silico studies and fluorescence binding assays of potential anti-prion compounds reveal an important binding site for prion inhibition from PrPC to PrPSc

2 references

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

5 May 2024

https://opencitations.net/index/api/v1/citations/10.1016/J.EJMECH.2014.07.045

Electrostatics in the stability and misfolding of the prion protein: salt bridges, self energy, and solvation

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

The Monte Carlo method

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Slow conformational dynamics in the hamster prion protein

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Cellular prion protein conformation and function

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Antiprion compounds that reduce PrP(Sc) levels in dividing and stationary-phase cells.

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

A systematic review of prion therapeutics in experimental models

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Synthesis of 9-substituted 2,3,4,9-tetrahydro-1H-carbazole derivatives and evaluation of their anti-prion activity in TSE-infected cells

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Variety of antiprion compounds discovered through an in silico screen based on cellular-form prion protein structure: Correlation between antiprion activity and binding affinity.

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Molecular docking of thiamine reveals similarity in binding properties between the prion protein and other thiamine-binding proteins

2 references

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

5 May 2024

https://opencitations.net/index/api/v1/citations/10.1007/S00894-013-1979-5

1H, 13C and 15N chemical shift referencing in biomolecular NMR

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Hot spots in prion protein for pathogenic conversion

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

2-Aminothiazoles as therapeutic leads for prion diseases

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Ph4Dock: pharmacophore-based protein-ligand docking

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Spongiform encephalopathy in transgenic mice expressing a point mutation in the β2-α2 loop of the prion protein

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

NMRPipe: a multidimensional spectral processing system based on UNIX pipes

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Structural and dynamic properties of the human prion protein

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Novel proteinaceous infectious particles cause scrapie

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2017.09.024

Identifiers

10.1016/J.BMC.2017.09.024

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/28951092

release_5p2v6pkfx5eljchbhkd72psrqa

1 reference

https://api.fatcat.wiki/v0/release/5p2v6pkfx5eljchbhkd72psrqa

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/28951092

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47739965&oldid=2169198656"